Clincosm LogoSign in Get a demo

iga nephropathy

Showing 1 - 25 of 89
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

Recruiting
  • Adenine Phosphoribosyltransferase Deficiency
  • +83 more
    • Bristol, South West, United Kingdom
      Zoe Plummer
    Sep 26, 2023

    IgA Nephropathy, Focal Segmental Glomerulosclerosis Trial in Nanjing (HS-10390 tablet, Placebo tablet)

    Recruiting
    • IgA Nephropathy
    • Focal Segmental Glomerulosclerosis
    • HS-10390 tablet
    • Placebo tablet
    • Nanjing, Jiangsu, China
      Zhongda Hospital, Affiliated to Southeast University
    Jul 12, 2023

    IgA Nephropathy, Immunoglobulin A Nephropathy Trial (BION-1301, Placebo)

    Not yet recruiting
    • IgA Nephropathy
    • Immunoglobulin A Nephropathy
    • (no location specified)
    May 2, 2023

    IgA Nephropathy, Immunoglobulin A Nephropathy Trial (Atrasentan, Placebo)

    Not yet recruiting
    • IgA Nephropathy
    • Immunoglobulin A Nephropathy
    • (no location specified)
    Apr 27, 2023

    IgA Nephropathy Trial in Shanghai (rituximab group)

    Active, not recruiting
    • IgA Nephropathy
    • rituximab group
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    Apr 9, 2023

    IgA Nephropathy Trial in China (Telitacicept, Placebo)

    Not yet recruiting
    • IgA Nephropathy
    • Telitacicept
    • Placebo
    • Hefei, Anhui, China
    • +79 more
    Mar 22, 2023

    IgA Nephropathy Trial (CM338)

    Not yet recruiting
    • IgA Nephropathy
    • CM338
    • (no location specified)
    Mar 7, 2023

    Diabetic Kidney Disease, IgA Nephropathy Trial (Placebo of SC0062, SC0062 low dose, SC0062 medium dose)

    Not yet recruiting
    • Diabetic Kidney Disease
    • IgA Nephropathy
    • Placebo of SC0062
    • +3 more
    • (no location specified)
    Jan 9, 2023

    IgA Nephropathy Trial in Korea, Republic of, United Kingdom, United States (BION-1301 Single Dose, Placebo Single Dose,

    Active, not recruiting
    • IgA Nephropathy
    • BION-1301 Single Dose
    • +3 more
    • Garden Grove, California
    • +26 more
    Jan 9, 2023

    IgA Nephropathy, IgAN Trial in Worldwide (AT-1501)

    Recruiting
    • IgA Nephropathy
    • IgAN
    • Liverpool, South Wales, Australia
    • +23 more
    Dec 5, 2022

    IgA Nephropathy, Focal Segmental Glomerulosclerosis, Alport Syndrome Trial in Worldwide (Atrasentan)

    Recruiting
    • IgA Nephropathy
    • +5 more
    • Huntsville, Alabama
    • +37 more
    Dec 1, 2022

    IgA Nephropathy Trial in Shanghai

    Recruiting
    • IgA Nephropathy
      • Shanghai, Shanghai, China
        Ruijin Hospital, Shanghai JiaoTong University School of Medicine
      Nov 1, 2022

      Bortezomib, Glomerulonephritis, MN Trial in Shanghai (Bortezomib)

      Recruiting
      • Bortezomib
      • +5 more
      • Shanghai, Shanghai, China
        Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
      Oct 28, 2022

      IgA Nephropathy Trial in Hangzhou (Telitacicept, Placebo)

      Not yet recruiting
      • IgA Nephropathy
      • Hangzhou, Zhejiang, China
        The Second Affiliated Hospital of Zhejiang University School of
      Oct 25, 2022

      Paroxysmal Nocturnal Hemoglobinuria, C3 Glomerulopathy, IgA Nephropathy Trial in Korea, Republic of, New Zealand, Thailand

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • +2 more
      • Camperdown, New South Wales, Australia
      • +19 more
      Sep 13, 2022

      IgA Nephropathy, Immunoglobulin A Nephropathy Trial in Worldwide (Atrasentan, Placebo)

      Recruiting
      • IgA Nephropathy
      • Immunoglobulin A Nephropathy
      • Birmingham, Alabama
      • +119 more
      Aug 17, 2022

      IgA Nephropathy Trial in Worldwide (Placebo, LNP023)

      Recruiting
      • IgA Nephropathy
      • Huntsville, Alabama
      • +193 more
      Aug 10, 2022

      IgA Nephropathy Trial in Qingdao (SHR-2010 injection, SHR-2010 injection )

      Recruiting
      • IgA Nephropathy
      • SHR-2010 injection
      • SHR-2010 injection placebo
      • Qingdao, Shandong, China
        the Affiliated Hospital of Qingdao University
      Jul 12, 2022

      IgA Nephropathy, Berger Disease Trial in Worldwide (Atacicept, Placebo to match Atacicept)

      Active, not recruiting
      • IgA Nephropathy
      • Berger Disease
      • Atacicept
      • Placebo to match Atacicept
      • Tucson, Arizona
      • +75 more
      Jul 6, 2022

      TESTING -ON Post-Trial ObservatioNal Cohort Study

      Not yet recruiting
      • IgA Nephropathy
      • +3 more
        • Kingswood, New South Wales, Australia
        • +59 more
        Jun 21, 2022

        IgA Nephropathy Trial in Xi'an (education and monitoring)

        Recruiting
        • IgA Nephropathy
        • education and monitoring
        • Xi'an, Shaanxi, China
          First affiliated hospital of Xi'an Jiaotong University
        Apr 26, 2022

        IgA Nephropathy, Proteinuria in Nephrotic Range, Immunosuppressive Treatment Trial in Beijing (Corticosteroid, Cyclophosphamide,

        Recruiting
        • IgA Nephropathy
        • +2 more
        • Beijing, China
          Peking University First Hospital
        Apr 21, 2022

        IgA Nephropathy, CKD Associated With Type 1 Diabetes, Focal Segmental Glomerulosclerosis Trial in United States (Bardoxolone

        Completed
        Has Results
        • IgA Nephropathy
        • +3 more
        • Bardoxolone methyl capsules
        • Birmingham, Alabama
        • +29 more
        Mar 15, 2022

        IgA Nephropathy Trial in United States (Telitacicept 160mg, Telitacicept 240mg, Placebo)

        Recruiting
        • IgA Nephropathy
        • Telitacicept 160mg
        • +2 more
        • Los Angeles, California
        • +15 more
        Feb 7, 2022

        IgA Nephropathy Trial in Doral, Kyiv (AVB-S6-500)

        Terminated
        Has Results
        • IgA Nephropathy
        • Doral, Florida
        • +1 more
        Jan 18, 2022